Great news on the $6.5M IDX899 milestone, which constitutes about half a quarter of operating cash burn (#msg-45351175). Perhaps a financing before inking a partnership for IDX184 won’t be needed after all, but I still expect a financing by mid-summer if an IDX184 deal has not been consummated.
The size of the payment ($6.5M) suggests that IDIX met more than one—and perhaps all—of the preclinical milestones laid out in #msg-45620605.